Bibliography
- LEE JC, KUMAR S, GRISWOLD DE et al.: Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology (2000) 47:185–201.
- ••Excellent review from a leading group.
- HERLAAR E, BROWN Z: p38 MAPK signalling cascades in inflammatory disease. MoL Med. Today (1999) 5:439–448.
- ••Good, well-illustrated review.
- BOEHM JC, ADAMS JL: New inhibitors of p38 kinase. Expert Opin. Ther. Patents (2000) 10:25–37.
- ••Reasonably up-to-date review of the patentliterature.
- DUMAS J, HATOUM-MOKDAD H, SIBLEY R et a/.: 1-Phenyl-5-pyrazoly1 ureas: potent and selective p38 kinase inhibitors. Bioorg. Med. Chem. Lett. (2000) 10:(18)2051–2054.
- KNOLKER HJ, BOESE R, HITZEMAN R: Imidazole derivatives: part 4. Heterocycles (1989) 29:1551–1558.
Websites
- http://www.gsk.com/financial/ product_pipeline.htm GlaxoSmithKline product pipeline